title: Alteration in the pharmacokinetic disposition of ciprofloxacin by simultaneous administration of azlocillin.
abstract: Healthy subjects were given single intravenous doses of ciprofloxacin, azlocillin, and the two drugs simultaneously on separate occasions. High-pressure liquid chromatographic analysis was used to assay the concentrations of both drugs in serum and urine. Pharmacokinetic parameters were calculated by noncompartmental methods. The total body (CL), renal (CLR), and nonrenal (CLNR) clearances; steady-state volume of distribution (Vss); and fractional urinary excretion of ciprofloxacin were all markedly decreased with the simultaneous administration of azlocillin. The disposition of azlocillin was unchanged when it was given with ciprofloxacin compared to when it was given alone. The pharmacokinetic parameters (mean +/- standard deviation) of ciprofloxacin given alone versus in combination with azlocillin were as follows: CL, 52.2 +/- 9.2 versus 33.9 +/- 6.0 liters/h (P less than 0.0005); CLR, 26.5 +/- 4.8 versus 16.2 +/- 4.2 liters/h (P less than 0.0005); CLNR, 25.8 +/- 5.5 versus 17.7 +/- 4.0 liters/h (P less than 0.03); Vss, 224 +/- 30 versus 166 +/- 41 liters (P less than 0.01); fractional urinary excretion, 0.56 +/- 0.06 versus 0.43 +/- 0.04 (P less than 0.002), respectively. This interaction resulted in significantly higher and more prolonged concentrations of ciprofloxacin in serum, which may be beneficial in the treatment of serious gram-negative bacterial infections, but it could also produce greater toxicity or result in more pronounced effects on oxidative drug metabolism of other medications.
authors.affiliation: Department of Pharmaceutical Services, University of California, Los Angeles 90024.
authors.forename: S L
authors.initials: SL
authors.lastname: Barriere
authors.forename: D H
authors.initials: DH
authors.lastname: Catlin
authors.forename: P L
authors.initials: PL
authors.lastname: Orlando
authors.forename: A
authors.initials: A
authors.lastname: Noe
authors.forename: R W
authors.initials: RW
authors.lastname: Frost
mesh_terms: D000328:Adult; D001390:Azlocillin / Q000494:pharmacology*; D002851:Chromatography, High Pressure Liquid; D002939:Ciprofloxacin / Q000493:pharmacokinetics*; D004347:Drug Interactions; D006207:Half-Life; D006801:Humans; D008297:Male; D008802:Mezlocillin / Q000032:analysis
chemical_list: D002939:Ciprofloxacin; D001390:Azlocillin; D008802:Mezlocillin